Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study.

Abstract OBJECTIVES: Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Umifenovir (ArbidolĀ®) is an antiviral drug being used to treat influenza in Russia and China. This study aimed to investigate the effectiveness […]

Click here to view original web page at Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: A retrospective study.